US › Healthcare

Catheter Precision Inc. (VTAK)

US · Healthcare · Medical Devices

$0.15-2.55%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.0M

Revenue YoY

+380.7%

Net profit

$-3.3M

EPS

$-0.92

Net margin

-323.4%

Key statistics

Market cap

$566,686

Forward P/E

0.0

P/B

0.03

Book value

$4.87

EPS (TTM)

$-4.22

52-week high

$3.20

52-week low

$0.15

50-day MA

$0.35

200-day MA

$1.17

Beta

0.47

Analyst view

Analysts rate Catheter Precision Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

20.02%

Institutions

0.66%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Catheter Precision Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.